InsiderTrades

Form 4 for PMN ProMIS Neurosciences Inc.

Accepted 2025-09-30 00:00:00 ET · period of report 2025-07-25 · accession 0001104659-25-095035 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-09-30 2025-07-25 PMN Jeremy M. Sclar 2012 Irrevocable Family Trust 10% X - OptEx — +2.09M 3.01M +228% —
D 2025-09-30 2025-07-29 PMN Jeremy M. Sclar 2012 Irrevocable Family Trust 10% P - Purchase — +3.14M 3.14M New —
DM 2025-09-30 2025-07-25 PMN Jeremy M. Sclar 2012 Irrevocable Family Trust 10% X - OptEx $0.00 -2.09M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares, no par value 2025-07-25 X A 697,674 — 3,710,459 D — — (F3) On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
2 Common Common Shares, no par value 2025-07-25 X A 697,674 — 2,315,111 D — — (F1) On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
3 Common Common Shares, no par value 2025-07-25 X A 697,674 — 3,012,785 D — — (F2) On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
4 Derivative Warrant to Purchase Common Shares 2025-07-29 P A 3,139,533 — 3,139,533 D — · — to — 3,139,533 Common Shares (F4) On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance.
5 Derivative Tranche A Common Share Purchase Warrants 2025-07-25 X D 697,674 $0.00 0 D — · — to — 697,674 Common Shares (F1) On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
6 Derivative Tranche B Common Share Purchase Warrants 2025-07-25 X D 697,674 $0.00 0 D — · — to — 697,674 Common Shares (F2) On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
7 Derivative Tranche C Common Share Purchase Warrants 2025-07-25 X D 697,674 $0.00 0 D — · — to — 697,674 Common Shares (F3) On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.